Expanded Access Program With Nivolumab to Treat Melanoma

Part of paid clinical trials in Mobile, Alabama.

Sponsor
Bristol-Myers Squibb
Study ID
NCT02142218
Status
No Longer Available

Conditions

  • Stage III (Unresectable) or Stage IV Advanced Melanoma

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this program is to provide treatment with nivolumab to subjects with Stage III or Stage IV advanced melanoma.

Key Dates

Start date
Jun 30, 2014
Status verified
Sep 2016
Primary completion
May 31, 2018
Completion
May 31, 2018

Locations (23)

FacilityCityStateZIPSite coordinators
Local InstitutionMobileAlabama36604-
Southern Cancer Center PcMobileAlabama36608-
Local InstitutionEncinitasCalifornia92024-
Local InstitutionWashington D.C.District of Columbia20057-
Lynn Cancer Institute At Boca Raton Regional HospitalBoca RatonFlorida33486-
Cancer Specialists Of North FloridaJacksonvilleFlorida32256-
Mount Sinai Comprehensive Cancer CenterMiami BeachFlorida33140-
Florida HospitalOrlandoFlorida32803-
Winship Cancer InstituteAtlantaGeorgia30322-
Summit Cancer CareSavannahGeorgia31404-
Oncology Specialists, S.C.Park RidgeIllinois60068-
Oncology Hematology Associates Of Sw InNewburghIndiana47630-
Sidney Kimmel Comprehensive Cancer Center At Johns HopkinsLuthervilleMaryland21093-
Nebraska Cancer SpecialistsOmahaNebraska68130-
Comprehensive Cancer Centers Of NevadaLas VegasNevada89148-
North Shore Hematology/Oncology Associates, P.C.East SetauketNew York11733-
Icahn School Of Medicine At Mount SinaiNew YorkNew York10029-
Mid Ohio Oncology/Hematology, Inc,DbaColumbusOhio43219-
Lehigh Valley Health NetworkAllentownPennsylvania18103-
St. Luke'S HospitalBethlehemPennsylvania18015-
The Jones Clinic, PcGermantownTennessee38138-
Tennessee Oncology, PLLCNashvilleTennessee37203-
Waukesha Memorial HospitalWaukeshaWisconsin53188-

Find similar trials in Mobile, AL